Stockreport

Why Anavex Life Sciences (AVXL) Is Down 43.8% After EMA Setback for Lead Alzheimer's Drug [Yahoo! Finance]

Anavex Life Sciences Corp.  (AVXL) 
NASDAQ:AMEX Investor Relations: anavex.com/share-data
PDF a negative trend vote on the Marketing Authorisation Application for its lead Alzheimer's drug candidate, blarcamesine, following an oral explanation. This setback int [Read more]